TickerStat.comwe like data

BridgeBio Pharma Shares Outstanding History (BBIO)

BridgeBio Pharma reported 194.8M shares outstanding at the end of fiscal 2025.

View full BridgeBio Pharma company overview

BridgeBio Pharma annual shares outstanding history

BridgeBio Pharma annual shares outstanding

Fiscal yearPeriod endedShares outstandingChangeGrowth
20252025-12-31194.8M4.7M+2.49%
20242024-12-31190.0M15.0M+8.55%
20232023-12-31175.1M24.5M+16.24%
20222022-12-31150.6M3.3M+2.23%
20212021-12-31147.3M24.5M+19.94%
20202020-12-31122.8M−808,898−0.65%
20192019-12-31123.7M31.6M+34.33%
20182018-12-3192.1M——

BridgeBio Pharma Share Buyback History

A share buyback, also called a stock repurchase, is when a company uses cash to buy its own shares. BridgeBio Pharma share buyback history shows the reported cash used for repurchases. Buybacks can reduce shares outstanding, but issuance, stock-based compensation, acquisitions, and stock splits can change the share count separately.

BridgeBio Pharma used $48.3M to repurchase common stock in fy 2025. Across the latest 5 reported fiscal years, total share repurchases were $248.3M. The latest reported quarter showed $127.5M of share repurchases.

BridgeBio Pharma annual share buyback history
Fiscal yearPeriod endedShare repurchases
20252025-12-31$48.3M
20242024-12-31$0
20232023-12-31$0
20222022-12-31$0
20212021-12-31$200.0M
20202020-12-31$75.0M

TickerStat uses SEC-reported cash payments for common-stock repurchases. The amounts describe capital returned through buybacks; they are not a forecast or a measure of the number of shares retired.

BridgeBio Pharma shares outstanding trends

Over the last five fiscal years, BridgeBio Pharma's shares outstanding moved from 122.8M to 194.8M, a change of 71.9M. The latest reported quarter, Q2 2026, shows 195.3M.

About the metric

What shares outstanding means

Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.

Calculation and source

SEC-reported period-end shares

TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review BridgeBio Pharma source filings ↗

Community posts

View community